Summary:
A randomized, double-blind, parallel group, placebo-controlled study to investigate the efficacy, safety, and tolerability of ML-004 in adolescents and adults with autism spectrum disorders (ASD)
Criteria:- Be 12-45 years old
- Be diagnosed with autism spectrum disorder (ASD)
- Have a care/study partner willing to assist during the study
- Additional criteria applies
Qualified Participants May Receive:
- Compensation up to $870 for time and travel
- Study-related care at no cost
- No insurance needed and transportation provided